@the_news_21
National Technical Advisory Group on Immunization (NTAGI) has approved Serum Institute of India’s COVID-19 vaccine Covovax for the 12-17 age group, sources told news agency ANI.
Last month, an expert panel of the country’s central drug authority recommended granting emergency use authorisation (EUA) to Covovax for the 12-17 age group.
TheNews21 is a leading national English news portal. Operating from the island city of Mumbai, it covers regional and federal current affairs related to politics apart from major foreign affairs issues. The portal also hosts in-depth investigation features, developments in the business sector, and keeps a pulse on the world of sports and entertainment.
This article had me hooked! For those curious, here’s more: DISCOVER MORE. What are your thoughts?